ClinicalTrials.Veeva

Menu

Determining the Most Efficient Screening Cut Off Levels for Phenylketonuria (PKU)

C

Central Hospital, Nancy, France

Status

Completed

Conditions

PKU

Study type

Observational

Funder types

Other

Identifiers

NCT06629987
2022PI186

Details and patient eligibility

About

studying the screening of PKU in france with the new tandemMS

Full description

Nationwide cohort study of the new pku screening for patient beetwen 180 and 360 µmol/L.

Enrollment

360 patients

Sex

All

Ages

3+ days old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • having screening in france

Exclusion criteria

  • refusing neonatal screening

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems